Pay in 4 interest-free payments of $7.24 Learn more
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
Such statements include, but are not limited to, any statements relating to our financial outlook and guidance, including our mission to drive top-line growth and profitability and our ability to attain our medium- and long-term financial targets
Confirm shipping logistics and cold chain requirements
Compounded retatrutide is a separate category and the FDA has issued public statements warning about online sellers using research-use labels
Unlike current GLP-1 receptor agonists such as semaglutide (Ozempic, Wegovy), Retatrutide is a triple hormone receptor agonistactivating GLP-1, GIP, and glucagon receptors simultaneously
Retatrutide is an investigational triple incretin receptor agonist targeting GLP-1, GIP, and glucagon receptors currently in Phase 3 trials with no global regulatory approval
This is consistent with the understanding that obesity is a chronic condition requiring ongoing management
US$ 27.26
US$ 22.71
US$ 26.82
US$ 23.10
US$ 27.53
US$ 28.83
US$ 28.75
US$ 25.52
US$ 26.74
US$ 28.91
US$ 22.14
